	販売および管理費		日付
AbbVie	USD 3.58B	316M	2026-03
Alterity Therapeutics Limited	AUD 1.45M	703.96K	2025-12
Amgen	USD 1.58B	354M	2026-03
AstraZeneca	USD 5.06B	455M	2026-03
Bristol-Myers Squibb	USD 1.62B	564M	2026-03
Cipla	INR 13.25B	101.8M	2025-12
Clal Biotechnology	ILS 3.31M	513K	2022-12
Compugen	USD 2.21M	120K	2025-12
CSL	USD 1.23B	498M	2025-12
Eisai	JPY 119.54B	7.82B	2026-03
Eli Lilly	USD 2.93B	198M	2026-03
Gilead Sciences	USD 1.45B	326M	2026-03
GlaxoSmithKline	GBP 2.12B	558M	2026-03
Grifols	EUR 320.45M	12.65M	2025-12
Incyte	USD 328.1M	62.31M	2026-03
Infinity Pharmaceuticals	USD 3.75M	2.19M	2023-06
Ionis Pharmaceuticals	USD 151M	21M	2026-03
J&J	USD 6.03B	719M	2026-03
Novartis	USD 3.14B	296M	2026-03
Pfizer	USD 2.92B	1.16B	2026-03
Plus Therapeutics	USD 3.49M	559K	2025-12
Roche Holding	CHF 7.28B	3.99B	2025-12
TG Therapeutics	USD 73.14M	22.42M	2026-03